Androstadienone

Androstadienone is a 16-androstene steroid, formally androsta-4,16-dien-3-one, related to testosterone metabolism but lacking androgenic or anabolic effects. It is one of several volatile androstene steroids found on human skin and in bodily fluids, and it occurs in higher amounts in men, notably in axillary (underarm) sweat and in saliva and semen.

The compound is best known from research into human chemosignaling. Several controlled studies report that exposure to androstadienone, often at levels below the threshold of conscious smell, can shift a person's psychological and physiological state. Early work found that delivering small quantities reduced feelings of nervousness and tension and altered autonomic activity in women ^[4]. Later experiments reported improvements in mood and focus, with the effects depending on social context, such as whether the experimenter was male or female ^[2].

Other studies point to effects on attention and hormones. In one series of experiments, androstadienone selectively sharpened attention toward emotionally meaningful information rather than to neutral or purely cognitive tasks ^[3]. In another, simply smelling the compound helped sustain higher levels of the stress hormone cortisol in women, showing that a single component of male sweat can influence endocrine balance in others ^[1]. Brain-imaging work by several groups has reported that androstadienone can activate regions including the hypothalamus, particularly in women.

Despite these findings, androstadienone is described as a putative rather than an established human pheromone. Human pheromone research is contentious: effects are often small, context-dependent, and inconsistent between studies, and humans lack a clearly functional vomeronasal organ of the kind that detects pheromones in many other mammals. The scientific community has not reached consensus that androstadienone functions as a true pheromone.

Commercially, androstadienone is sometimes added to colognes and "pheromone" products marketed to enhance attractiveness, claims that outrun the strength of the evidence. It is not a medicine or a controlled substance and has no recognized therapeutic use.

Androstadienone is an endogenous steroid that in research is applied in tiny amounts as an olfactory or topical stimulus, typically a micromolar solution placed under the nose or on the upper lip, and is not ingested; it is not a controlled substance and has no established systemic toxicity at the quantities used. The main measurable effects are transient and physiological, including small changes in cortisol, sympathetic arousal, mood and attention, and these vary with sex, hormonal state, the sex of the experimenter and the social framing of the test.

A practical caveat is perceptual rather than toxicological: many people find the odor unpleasant or urinous, a substantial minority are specifically anosmic to it, and repeated exposure can shift its perceived quality. Marketed "pheromone" attractant products containing androstadienone are not supported by robust evidence and should not be regarded as having a validated behavioral effect.

Androstadienone emerged from mid-twentieth-century work on the odorous 16-androstene steroids, a family first characterized in pig testis and linked to "boar taint" and to the boar salivary sex-attractant androstenone. Analytical studies through the 1980s and 1990s using gas chromatography-mass spectrometry identified androstadienone in human plasma and demonstrated its presence in apocrine sweat and axillary secretions, establishing it as a genuine constituent of male body odor.

Interest in a behavioral role intensified during the 1990s vomeronasal-organ era, and the landmark psychological studies by Jacob and McClintock around 2000 reported context-dependent effects on mood and physiology, followed by the influential brain-imaging work of Savic, Berglund and colleagues showing sex-differentiated and sexual-orientation-differentiated hypothalamic activation.

A pivotal 2007 study reported that smelling this single component of male sweat raised cortisol in women, cementing its status as the flagship candidate human chemosignal. The 2007 identification of OR7D4 as its olfactory receptor, and the discovery that receptor genotype governs its perception, reframed the compound as an odorant with a defined receptor rather than a vomeronasal pheromone.

From the mid-2010s onward, critical reviews, notably by Wyatt, and pre-registered replication attempts questioned the reliability of many behavioral claims, and commentary as recent as 2025 concluded that its pheromone status remains unproven. In parallel, the closely related 3-ol steroid was advanced as the investigational pherine drug fasedienol for social anxiety disorder.

Androstadienone occupies an unusual position as simultaneously the most cited candidate human pheromone and a cautionary example in the reproducibility debate. Within chemosensory science it is respected as a real and well-characterized component of male body odor with measurable, receptor-defined perceptual effects and reproducible activation of the hypothalamus on imaging.

Its reputation as a behaviorally active "pheromone," however, is heavily qualified: documented effects on mood, attention, cooperation, dominance perception and mate choice are typically small, sensitive to context and sex, and inconsistently replicated, and several pre-registered studies have reported null results. In the consumer market it is sold in attractant colognes and "pheromone" products on the strength of these early findings, a use that the scientific literature does not support. The compound is therefore best understood as a legitimate and fascinating object of chemosensory research whose popular reputation as a human sex attractant outruns the evidence.